{
    "clinical_study": {
        "@rank": "8232", 
        "arm_group": [
            {
                "arm_group_label": "sevorane", 
                "arm_group_type": "Active Comparator", 
                "description": "Sevorane 4% concentration during anesthesia induction"
            }, 
            {
                "arm_group_label": "sevorane %7", 
                "arm_group_type": "Active Comparator", 
                "description": "Sevorane 7% concentration during anesthesia induction"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study was to investigate the effects of different doses of sevoflurane\n      used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and\n      recovery profiles"
        }, 
        "brief_title": "Sevoflurane in Electroconvulsive Therapy", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "ECT", 
            "Anesthesia"
        ], 
        "detailed_description": {
            "textblock": "Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean\n      arterial pressure (MAP) values, and recovery times were recorded."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Study included 25 patients of American Society of Anesthesiologists (ASA) physical\n             status I-II aged between 18-60 years who were scheduled for ECT sessions under\n             general anesthesia\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Cerebrovascular disease\n\n          -  Epilepsy\n\n          -  Unstable cardiovascular disease\n\n          -  Chronic obstructive pulmonary disease; and\n\n          -  Renal or hepatic failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01905904", 
            "org_study_id": "ulk\u00fc_2"
        }, 
        "intervention": {
            "arm_group_label": [
                "sevorane", 
                "sevorane %7"
            ], 
            "description": "Sevorane 4% Sevorane 7%", 
            "intervention_name": "sevorane", 
            "intervention_type": "Drug", 
            "other_name": "Sevoflurane"
        }, 
        "intervention_browse": {
            "mesh_term": "Sevoflurane"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "electroconvulsive therapy", 
            "seizures", 
            "sevoflurane"
        ], 
        "lastchanged_date": "July 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Malatya", 
                    "country": "Turkey", 
                    "zip": "44100"
                }, 
                "name": "Inonu Un\u0131versity School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Comparision of Different Doses of Sevoflurane for Induction of General Anesthesia in Electroconvulsive Therapy", 
        "overall_official": {
            "affiliation": "Inonu University", 
            "last_name": "Huseyin Toprak, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure", 
            "safety_issue": "No", 
            "time_frame": "taken prior to the seizure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01905904"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Inonu University", 
            "investigator_full_name": "\u00dclk\u00fc \u00d6zg\u00fcl", 
            "investigator_title": "assistant profesor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "sevoflurane used in electroconvulsive therapy (ECT) on hemodynamic response.", 
            "safety_issue": "No", 
            "time_frame": "taken prior to the seizure"
        }, 
        "source": "Inonu University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inonu University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}